Test ID NTXPR NTX-Telopeptide, Urine
Useful For
As an adjunct in the diagnosis of medical conditions associated with increased bone turnover
Monitoring effectiveness of antiresorptive therapy in patients treated for osteopenia, osteoporosis, Paget disease, or other metabolic bone disorders
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
NTXCT | Creatinine, Random, U | No | Yes |
NTXUR | NTX-Telopeptide, U | No | Yes |
Method Name
NTXUR: Chemiluminescence Immunoassay
NTXCT: Enzymatic Colorimetric Assay
Reporting Name
NTX-Telopeptide, USpecimen Type
UrineSpecimen Required
Patient Preparation: For 24 hours before specimen collection do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.
Container/Tube: Plastic, 13-mL urine tube
Specimen Volume: 4 mL
Collection Instructions:
1. Collect second morning void.
2. No preservative.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen (preferred) | 28 days | |
Refrigerated | 14 days | ||
Ambient | 72 hours |
Reference Values
All units are reported in nmol bone collagen equivalents (BCE)/mmol creatinine.
Pediatric
Males:
Tanner Stage I: 55-508 nmol BCE/mmol creatinine
Tanner Stage II: 21-423 nmol BCE/mmol creatinine
Tanner Stage III: 27-462 nmol BCE/mmol creatinine
Tanner Stage IV: <609 nmol BCE/mmol creatinine
Tanner Stage V: <240 nmol BCE/mmol creatinine
Females:
Tanner Stage I: 6-662 nmol BCE/mmol creatinine
Tanner Stage II: 193-514 nmol BCE/mmol creatinine
Tanner Stage III: 13-632 nmol BCE/mmol creatinine
Tanner Stage IV: <389 nmol BCE/mmol creatinine
Tanner Stage V: <132 nmol BCE/mmol creatinine
Adult (≥18 years of age)
Males:
21-83 nmol BCE/mmol creatinine
Females:
Premenopausal: 17-94 nmol BCE/mmol creatinine
Postmenopausal: 26-124 nmol BCE/mmol creatinine
Day(s) Performed
Monday, Thursday
Report Available
Same day/1 to 5 daysPerforming Laboratory

Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82570
82523
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
NTXPR | NTX-Telopeptide, U | 44712-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
NTXCT | Creatinine, Random, U | 2161-8 |
NTX | NTX | 27939-8 |
NTXCR | NTX-Telopeptide, U | 44712-8 |